cms_SC: 94
Data source: Big Local News · About: big-local-datasette
rowid | facility_name | facility_id | address | city | state | zip | inspection_date | deficiency_tag | scope_severity | complaint | standard | eventid | inspection_text | filedate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
94 | ELLEN SAGAR NURSING CENTER | 425012 | 1817 JONESVILLE HIGHWAY | UNION | SC | 29379 | 2017-05-11 | 329 | E | 1 | 1 | SD8911 | **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** > Based on record review and interviews, the Registered Pharmacist (RPH) failed to identify irregularity for two consecutive months related to the approved gradual dose reduction (GDR) of antipsychotic medication for 2 of 5 residents reviewed for unnecessary medications. The findings included: The facility admitted Resident #120 2/3/17 with [DIAGNOSES REDACTED]. Record review on 5/10/17 at approximately 1:49 PM revealed a Pharmacist recommendation dated 2/23/17 for Physician to please re-evaluate the need for continued use of ziprasidone, perhaps considering a gradual dosage reduction to 20 milligrams (mg) by mouth daily for delusions associated with [MEDICAL CONDITION], with the end goal of discontinuation of therapy if possible. Physician approved this request by checking the response I accept the recommendation(s) above, please implement as written with a signature date of 3/2/17. Further review of physicians orders initiated on 3/2/17 reveal the order change [MEDICATION NAME] to 0.25 mg tabs-take 1 tab by mouth four times daily (QID) which was signed by the Nurse Practitioner on 3/6/17. Additional review of the monthly physician orders [REDACTED]. During interview with MD#1 and DON on 5/11/17 at 10:00 AM, MD#1 verified that s/he did approve the GDR for ziprasidone on 3/2/17 that was recommended by the RPH during February 2017 MMR. MD#1 and DON then reviewed Resident #120's medical record during interview after which both verified that the pharmacy recommendation for GDR of ziprasidone that was approved on 3/2/17 had not been initiated as ordered with 2 subsequent RPH monthly MMR's on 3/9/17 and 4/13/17 that did not identify the irregularity. DON and MD both verified that Resident #120 should have been receiving ziprasidone 20 mg capsule by mouth once daily since 3/2/2017. DON and MD #1 both verified that for 71 days, Resident #120 received a daily unnecessary dose of ziprasidone for a total of 71 doses. At the conclusion of the interview, MD #1 initiated an order to decrease the ziprasidone from 20 mg twice daily to 20 mg once daily to begin on 5/11/17. The facility admitted Resident #31 with [DIAGNOSES REDACTED]. Review of Resident #31's record on 5-10-17 at 4:07 p.m. revealed that a repeated pharmacy recommendation from 2-23-17 stated to add an appropriate [DIAGNOSES REDACTED]. The physician indicated to discontinue the medication and signed the pharmacy recommendation on 4-20-17. The order to discontinue the medication was not written until 4-25-17, as evidenced by the 'Physicians Order Form'. The initial pharmacy recommendation was signed by the physician on 3-1-17 but did not indicate a response from the physician regarding the recommendation. Review of the resident's Medication Administration Record [REDACTED]. The records were reviewed by the Director of Nursing DON on 5-11-17 at 12:28 p.m. and confirmed that an order should have been written and the ordered should have been discontinued prior to 4-25-17. | 2020-09-01 |